HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Charles C Chu Selected Research

Immunoglobulin Constant Regions

3/2015A novel engineered VEGF blocker with an excellent pharmacokinetic profile and robust anti-tumor activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Charles C Chu Research Topics

Disease

20B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2018 - 06/2005
5Neoplasms (Cancer)
12/2020 - 06/2005
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
03/2017 - 06/2002
2Infections
01/2014 - 01/2011
1Lymphoma (Lymphomas)
01/2021
1Chickenpox
01/2021
1Herpes Zoster
01/2021
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
10/2020
1Hemolytic Anemia
10/2020
1Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
03/2017
1Macular Degeneration (Age-Related Maculopathy)
03/2015
1Disease Progression
11/2014
1Human Influenza (Influenza)
01/2014
1Male Infertility (Male Sterility)
01/2007
1Varicocele
01/2007
1Breast Diseases (Breast Disease)
06/2005
1Rheumatoid Arthritis
05/2003
1Common Variable Immunodeficiency
07/2002

Drug/Important Bio-Agent (IBA)

8Immunoglobulins (Immunoglobulin)IBA
09/2017 - 10/2009
5AntibodiesIBA
03/2017 - 12/2008
4Proteins (Proteins, Gene)FDA Link
03/2015 - 12/2012
3Monoclonal AntibodiesIBA
12/2020 - 10/2009
3AntigensIBA
03/2017 - 01/2014
2Rituximab (Mabthera)FDA Link
10/2020 - 10/2018
2AICDA (activation-induced cytidine deaminase)IBA
01/2017 - 12/2012
2Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
01/2011 - 12/2008
2Myosin Heavy Chains (Myosin Heavy Chain)IBA
05/2010 - 12/2008
2EpitopesIBA
10/2009 - 11/2008
2Complementary DNA (cDNA)IBA
05/2003 - 07/2002
1Glycoproteins (Glycoprotein)IBA
01/2021
1obinutuzumabIBA
10/2018
1ocaratuzumabIBA
10/2018
1ofatumumabFDA Link
10/2018
1CarbohydratesIBA
03/2017
1DNA (Deoxyribonucleic Acid)IBA
03/2017
1Interleukin-15 (Interleukin 15)IBA
08/2015
1Angiogenesis InhibitorsIBA
03/2015
1Bevacizumab (Avastin)FDA Link
03/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2015
1Recombinant ProteinsIBA
03/2015
1Immunoglobulin Constant RegionsIBA
03/2015
1Pharmaceutical PreparationsIBA
03/2015
1Neutralizing AntibodiesIBA
01/2014
1Leucine (L-Leucine)FDA Link
01/2014
1Phenylalanine (L-Phenylalanine)FDA Link
01/2014
1Hemagglutinins (Hemagglutinin)IBA
01/2014
1anti-IgMIBA
04/2013
1Biological ProductsIBA
12/2012
1AutoantigensIBA
02/2012
1Protein Kinases (Protein Kinase)IBA
01/2011
1Complementarity Determining Regions (Complementarity Determining Region)IBA
12/2008
1Contraceptive Agents (Contraceptives)IBA
01/2007
1Ion Channels (Ion Channel)IBA
01/2007
1CholesterolIBA
01/2007
1Interleukin-10 (Interleukin 10)IBA
06/2005
1NucleotidesIBA
05/2003
1InterleukinsIBA
06/2002

Therapy/Procedure

3Therapeutics
01/2021 - 05/2012
1Heterologous Transplantation (Xenotransplantation)
04/2016